ASPN 2026 Abstract Submission Form

ASPN 2026 Abstract Submission Form

Submission Deadline: April 15, 2026
Abstract Title

Primary Presenter
Primary Presenter Name

First NameLast Name
Credentials
Affiliation
City/State
Phone Number
Please enter a valid phone number.
Email
example@example.com

Co-Presenter
Co-Presenter Name

First NameLast Name
Credentials
Affiliation
Phone Number
Please enter a valid phone number.
Email
example@example.com

Co-Presenter 2
Co-Presenter 2 Name

First NameLast Name
Credentials
Affiliation
Phone Number
Please enter a valid phone number.
Email
example@example.com

Collapse Stopper
Please attach your abstract which includes: Introduction, Objectives, Materials and Methods, Results, Conclusion, References (Author 1, Author 2, Author 3 et al. Title. Journal Year. Volume: start page-end page), Acknowledgements - please acknowledge any funding source and contributors to the research, Figure and Table Legend. Abstract should be no more than 500 words. References can be separate and will not impact word count. Please attach everything in one file, on separate pages. Uploaded document should be labeled last name.first name of the primary presenter.

Cancelof
Disclosures
Do any of the authors of this abstract have any commercial relationships to disclose? - If yes, please complete the Disclosure of Commercial Relationships.

YesNo
Is any device or drug required FDA approval identified as an important component of your presentation? - If yes, please complete the FDA Disclosure Form.

YesNo
Signature

Clear
Name

First NameLast Name
Date

MonthDayYear
Date
Presenter Biographical Form

This information must be submitted for the Primary Presenter only. Please type the information with your name and credentials exactly as you want them to appear in the published materials.
Name

First NameLast Name
Credentials
Professional Title
Facility
Work Phone Number
Please enter a valid phone number.
Mobile Phone Number
Please enter a valid phone number.
Academic Preparation/Institution
Please include: Relevant Training and Experience in this Area
Disclosure of Financial Relationships

All authors submitting abstracts for publications are required to disclose any relationships with industry that may direct bearing on relevant subject matter. The primary presenter must disclose any author/presenter who has relevant financial interest or other relationships occurring with the past 12 months with commercial companies or organizations.
Author Name

First NameLast Name

	Company	Company	Company	Company
Board Member/Trustee
Consultant/Advisor
Employee
Investigator
Investment/Stock Options/Shares
Meeting Participant/Lecturer
Owner
Scientific Study/Trial
Other (please specify)

Additional Form if needed
Author Name

First NameLast Name

	Company	Company	Company	Company
Board Member/Trustee
Consultant/Advisor
Employee
Investigator
Investment/Stock Options/Shares
Meeting Participant/Lecturer
Owner
Scientific Study/Trial
Other (please specify)

Additional Form if needed
Author Name

First NameLast Name

	Company	Company	Company	Company
Board Member/Trustee
Consultant/Advisor
Employee
Investigator
Investment/Stock Options/Shares
Meeting Participant/Lecturer
Owner
Scientific Study/Trial
Other (please specify)

Additional Form if needed
Author Name

First NameLast Name

	Company	Company	Company	Company
Board Member/Trustee
Consultant/Advisor
Employee
Investigator
Investment/Stock Options/Shares
Meeting Participant/Lecturer
Owner
Scientific Study/Trial
Other (please specify)

ASPN 2026 Abstract Submission Form

Disclosures

Presenter Biographical Form

Disclosure of Financial Relationships

FDA Disclosure

Abstract Submission Integrity Attestation

Detailed Commitment and Acceptance

Commitment to Presentation

Data Integrity and Scrutiny

Disclosure of Overlap

Optional: Disclosure of Preliminary or Related Work